Editor: Fabrizio Bruschi

Series Title: Frontiers in Parasitology

Water-borne Protozoa in Humans

Volume 2

eBook: US $39 Special Offer (PDF + Printed Copy): US $151
Printed Copy: US $131
Library License: US $156
ISSN: 2542-4211 (Print)
ISSN: 2542-422X (Online)
ISBN: 978-1-68108-434-3 (Print)
ISBN: 978-1-68108-433-6 (Online)
Year of Publication: 2017
DOI: 10.2174/97816810843361170201

Introduction

Several parasites are able to spread diseases through contaminated water. While the spread of diseases through contaminated water appears to have a greater correlation with a lack of access to clean water in low income populations in developing countries, there have been outbreaks of water-borne diseases in developed countries. Therefore, addressing water-borne diseases is a major public health concern worldwide. Water-borne Protozoa in Humans is a guide to protozoan infections linked to contaminated water.

Each chapter of this monograph covers the history, morphology, life cycle, global epidemiology, risk factors, immunology, symptoms, diagnosis, treatment and perspectives of control for each relevant protozoan parasite that can be found in contaminated water. These include Giardia duodenalis, Cryptosporidium, Free-living amoebae, Entamoeba histolytica/dispar and other pathogenic intestinal amoebae, Cystoisospora belli, cyclospora, microsporidia, and Blastocystis hominis.

This monograph is suitable for a broad readership which includes medical students, parasitologists, clinical microbiologists, epidemiologists, environmental health and water safety technicians, and public health personnel.

Indexed in: BIOSIS Previews, Book Citation Index, EBSCO, Zoological Record.

Contributors

Editor(s):
Fabrizio Bruschi
University of Pisa
Pisa
Italy




Contributor(s):
Claudia Ledda
Department of Experimental Medicine, Division of Microbiology and Clinical Microbiology, II Università di Napoli
Naples
Italy


Eduardo R. Cobo
Gastrointestinal Research Group, University of Calgary, Calgary
Alberta
Canada


Fabio Tosini
Department of Infectious, Parasitic and Immunomediated Diseases, Istituto Superiore di Sanità
Rome
Italy


Gianluigi Franci
Department of Experimental Medicine, Division of Microbiology and Clinical Microbiology, II Università di Napoli
Naples
Italy


Ildebrando Patamia
Department of Biomedical and Biotechnological Sciences, University of Catania
Catania
Italy


Kris Chadee
Gastrointestinal Research Group, University of Calgary, Calgary
Alberta
Canada


Marco Prato
Department of Biomedical and Biotechnological Sciences, University of Catania
Catania
Italy


Maria Elena Della Pepa
Department of Experimental Medicine, Division of Microbiology and Clinical Microbiology, II Università di Napoli
Naples
Italy


Marilena Galdiero
Department of Experimental Medicine, Division of Microbiology and Clinical Microbiology, II Università di Napoli
Naples
Italy


Massimiliano Galdiero
Department of Experimental Medicine, Division of Microbiology and Clinical Microbiology, II Università di Napoli
Naples
Italy


Nadia Aly E-Dib
Faculty of Medicine, Cairo University
Cairo
Egypt


Settimia Alfano
Department of Experimental Medicine, Division of Microbiology and Clinical Microbiology, II Università di Napoli
Naples
Italy


Showgy Maayeh
Department of Cell and Molecular Biology, Science for Life Laboratory, Uppsala University
Uppsala
Sweden


Simone M. Cacciò
Department of Infectious, Parasitic and Immunomediated Diseases, Istituto Superiore di Sanità
Rome
Italy


Staffan Svärd
Department of Cell and Molecular Biology, Science for Life Laboratory, Uppsala University
Uppsala
Sweden


Thomas Wetzel
Clínica Alemana School of Medicine,Universidad del Desarrollo
Santiago
Chile


Vinu Khanna
Department of Microbiology, Kasturba Medical College, Manipal
Karnataka
India


Ynes R. Ortega
Center for Food Safety, University of Georgia, Griffin
Georgia
USA




RELATED BOOKS

.Frontiers in Clinical Drug Research - Anti Infectives- Vol 9.
.COVID-19: Causes, Transmission, Diagnosis, and Treatment.
.Emerging Approaches to Tackle Neglected Diseases: From Molecule to End Product.
.COVID 19 – Monitoring with IoT Devices.